Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$42.05 - $47.77 $26,281 - $29,856
-625 Reduced 7.33%
7,906 $344,000
Q1 2022

May 13, 2022

BUY
$40.23 - $47.74 $6,034 - $7,161
150 Added 1.79%
8,531 $372,000
Q4 2021

Feb 08, 2022

BUY
$38.88 - $45.31 $5,637 - $6,569
145 Added 1.76%
8,381 $370,000
Q3 2021

Nov 12, 2021

BUY
$38.79 - $43.16 $20,946 - $23,306
540 Added 7.02%
8,236 $315,000
Q2 2021

Aug 12, 2021

BUY
$36.52 - $41.46 $48,571 - $55,141
1,330 Added 20.89%
7,696 $306,000
Q1 2021

May 13, 2021

BUY
$34.27 - $40.01 $46,949 - $54,813
1,370 Added 27.42%
6,366 $231,000
Q3 2019

Nov 12, 2019

SELL
$40.46 - $43.52 $4,652 - $5,004
-115 Reduced 2.25%
4,996 $213,000
Q1 2019

May 14, 2019

SELL
$38.57 - $42.69 $9,642 - $10,672
-250 Reduced 4.66%
5,111 $214,000
Q3 2018

Nov 02, 2018

SELL
$39.75 - $42.69 $59,426 - $63,821
-1,495 Reduced 21.81%
5,361 $215,000
Q2 2018

Aug 03, 2018

BUY
$39.61 - $42.76 $2,574 - $2,779
65 Added 0.96%
6,856 $276,000
Q4 2017

Feb 02, 2018

BUY
$35.34 - $41.9 $45,058 - $53,422
1,275 Added 23.11%
6,791 $0
Q3 2017

Nov 03, 2017

BUY
$39.44 - $41.55 $217,551 - $229,189
5,516
5,516 $224,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Pekin Hardy Strauss, Inc. Portfolio

Follow Pekin Hardy Strauss, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pekin Hardy Strauss, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pekin Hardy Strauss, Inc. with notifications on news.